A paper using https://t.co/pZmMRWDFKC (from @MMRRC) was just published in Cancer Discovery, see "PTP1B is an intracellular checkpoint that limits T…": https://t.co/o0si8YUWk9 (https://t.co/PB6lxMqGfq). Thank you for making your #methodsmatter. #Reproducibl
RT @CD_AACR: From the March issue: PTP1B is an intracellular #checkpoint that limits T cell and #CART cell anti-tumor #immunity by @florian…
RT @CD_AACR: From the March issue: PTP1B is an intracellular #checkpoint that limits T cell and #CART cell anti-tumor #immunity by @florian…
RT @CD_AACR: From the March issue: PTP1B is an intracellular #checkpoint that limits T cell and #CART cell anti-tumor #immunity by @florian…
RT @CD_AACR: From the March issue: PTP1B is an intracellular #checkpoint that limits T cell and #CART cell anti-tumor #immunity by @florian…
From the March issue: PTP1B is an intracellular #checkpoint that limits T cell and #CART cell anti-tumor #immunity by @florian_wiede, @TTiganis et al. https://t.co/NXmPaCwpMu @monash @PeterMacRes @PeterMacCC https://t.co/UHIjq1U7rG
@AACR @CD_AACR @TTiganis @florian_wiede @PeterMacCC @CSHL @Monash_FMNHS @MonashResearch @immunity_BDI And the link to the Cancer Discovery publication: https://t.co/W6oueAqY8f
And the link to the Cancer Discovery publication: https://t.co/ezfe8Wc6tW
RT @recherche_anima: 🧐👍 #cancer: une étude chez la #souris 🐁 révèle un nouveau point de contrôle immunitaire . Inhiber l'enzyme impliquée p…
🧐👍 #cancer: une étude chez la #souris 🐁 révèle un nouveau point de contrôle immunitaire . Inhiber l'enzyme impliquée permet de freiner la croissance tumorale https://t.co/U2T6izHJMU https://t.co/zrtFOFl55A
T:👉Bu hayvan çalışması, T hücrelerinde (savunma hücresi) protein tirozin fosfataz PTP1B'yi inhibe ederek, vücudun kansere karşı bağışıklık tepkisinin harekete geçirilebileceğini ve tümör büyümesinin baskılanmasına yardımcı olabileceğini göstermektedir. ht
👉 Identify protein tyrosine phosphatase 1B (PTP1B) is upregulated in intratumoral T cells and that its deletion or inhibition enhances T-cell antitumor activity and increases CAR T-cell effectiveness against solid tumors. #Immunotherapy https://t.co/vKFH4
A new approach for bolstering the ability of T cells to fight cancer https://t.co/V9mYItnqr0 "by inhibiting the protein tyrosine phosphatase PTP1B in T cells, the body's immune response to cancer can be mobilized, helping to repress tumor growth." https
Original manuscript is here: https://t.co/YKbYRTVkEW
RT @ElizSMcKenna: ICYMI in @CD_AACR: PTP1B is an intracellular #checkpoint that limits T cell and CAR T cell anti-tumor #immunity @florian_…
RT @ElizSMcKenna: ICYMI in @CD_AACR: PTP1B is an intracellular #checkpoint that limits T cell and CAR T cell anti-tumor #immunity @florian_…
RT @ElizSMcKenna: ICYMI in @CD_AACR: PTP1B is an intracellular #checkpoint that limits T cell and CAR T cell anti-tumor #immunity @florian_…
ICYMI in @CD_AACR: PTP1B is an intracellular #checkpoint that limits T cell and CAR T cell anti-tumor #immunity @florian_wiede @TTiganis @Monash @PeterMacRes @PeterMacCC #ASH21 https://t.co/wkYbJ6gtqO
RT @CD_AACR: PTP1B is an intracellular #checkpoint that limits T cell and CAR T cell anti-tumor #immunity. https://t.co/VUmEw3wWmi @florian…
RT @CD_AACR: PTP1B is an intracellular #checkpoint that limits T cell and CAR T cell anti-tumor #immunity. https://t.co/VUmEw3wWmi @florian…
RT @CD_AACR: PTP1B is an intracellular #checkpoint that limits T cell and CAR T cell anti-tumor #immunity. https://t.co/VUmEw3wWmi @florian…
PTP1B is an intracellular #checkpoint that limits T cell and CAR T cell anti-tumor #immunity. https://t.co/VUmEw3wWmi @florian_wiede @TTiganis @Monash @PeterMacRes @PeterMacCC https://t.co/mWGl9d9280
RT @NatRevClinOncol: PTP1B is an intracel checkpoint upregulated in T cells in tumours. T cell-specific PTP1B deletion enhanced antigen-ind…
RT @NatRevClinOncol: PTP1B is an intracel checkpoint upregulated in T cells in tumours. T cell-specific PTP1B deletion enhanced antigen-ind…
RT @NatRevClinOncol: PTP1B is an intracel checkpoint upregulated in T cells in tumours. T cell-specific PTP1B deletion enhanced antigen-ind…
RT @NatRevClinOncol: PTP1B is an intracel checkpoint upregulated in T cells in tumours. T cell-specific PTP1B deletion enhanced antigen-ind…
PTP1B is an intracellular checkpoint that limits T cell and CAR T cell anti-tumor immunity | Cancer Discovery https://t.co/lpha8WkAGD
RT @NatRevClinOncol: PTP1B is an intracel checkpoint upregulated in T cells in tumours. T cell-specific PTP1B deletion enhanced antigen-ind…
PTP1B is an intracel checkpoint upregulated in T cells in tumours. T cell-specific PTP1B deletion enhanced antigen-induced expansion and cytotoxicity of CD8+ T cells via STAT5 signalling and enhanced efficacy of CAR T cells against solid tumours in mice ht
RT @ElizSMcKenna: Now online in @CD_AACR: PTP1B is an intracellular #checkpoint that limits T cell and CAR T cell anti-tumor #immunity @flo…
RT @ElizSMcKenna: Now online in @CD_AACR: PTP1B is an intracellular #checkpoint that limits T cell and CAR T cell anti-tumor #immunity @flo…
RT @ElizSMcKenna: Now online in @CD_AACR: PTP1B is an intracellular #checkpoint that limits T cell and CAR T cell anti-tumor #immunity @flo…
Now online in @CD_AACR: PTP1B is an intracellular #checkpoint that limits T cell and CAR T cell anti-tumor #immunity @florian_wiede @TTiganis @Monash @PeterMacRes @PeterMacCC https://t.co/wkYbJ6gtqO
RT @TTiganis: PTP1B is an intracellular checkpoint that limits T cell and CAR T cell anti-tumor immunity https://t.co/SUpb4PfmQp
RT @TTiganis: PTP1B is an intracellular checkpoint that limits T cell and CAR T cell anti-tumor immunity https://t.co/SUpb4PfmQp
RT @TTiganis: PTP1B is an intracellular checkpoint that limits T cell and CAR T cell anti-tumor immunity https://t.co/SUpb4PfmQp
RT @TTiganis: PTP1B is an intracellular checkpoint that limits T cell and CAR T cell anti-tumor immunity https://t.co/SUpb4PfmQp
@alanlparker @SimonWad
RT @TTiganis: PTP1B is an intracellular checkpoint that limits T cell and CAR T cell anti-tumor immunity https://t.co/SUpb4PfmQp
RT @TTiganis: PTP1B is an intracellular checkpoint that limits T cell and CAR T cell anti-tumor immunity https://t.co/SUpb4PfmQp
PTP1B is an intracellular checkpoint that limits T cell and CAR T cell anti-tumor immunity https://t.co/l4dOBX7PL7 https://t.co/Q4OiXYHkls
RT @TTiganis: PTP1B is an intracellular checkpoint that limits T cell and CAR T cell anti-tumor immunity https://t.co/SUpb4PfmQp
Exciting work discovering new angles in cancer immunotherapy @TTiganis Florian and team. Great to see collaboration at work @MonashBDI @PMCC and @CSHL
Check out our latest paper now online at Cancer Discovery @CD_AACR!
RT @TTiganis: PTP1B is an intracellular checkpoint that limits T cell and CAR T cell anti-tumor immunity https://t.co/SUpb4PfmQp
RT @TTiganis: PTP1B is an intracellular checkpoint that limits T cell and CAR T cell anti-tumor immunity https://t.co/SUpb4PfmQp
PTP1B is an intracellular checkpoint that limits T cell and CAR T cell anti-tumor immunity https://t.co/s1ZhqPaUwZ
RT @TTiganis: PTP1B is an intracellular checkpoint that limits T cell and CAR T cell anti-tumor immunity https://t.co/SUpb4PfmQp
RT @TTiganis: PTP1B is an intracellular checkpoint that limits T cell and CAR T cell anti-tumor immunity https://t.co/SUpb4PfmQp
RT @TTiganis: PTP1B is an intracellular checkpoint that limits T cell and CAR T cell anti-tumor immunity https://t.co/SUpb4PfmQp
RT @TTiganis: PTP1B is an intracellular checkpoint that limits T cell and CAR T cell anti-tumor immunity https://t.co/SUpb4PfmQp
PTP1B is an intracellular checkpoint that limits T cell and CAR T cell anti-tumor immunity https://t.co/SUpb4PfmQp